These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29653204)

  • 1. EphA3 maintains radioresistance in head and neck cancers through epithelial mesenchymal transition.
    Kim SH; Lee WH; Kim SW; Je HU; Lee JC; Chang HW; Kim YM; Kim K; Kim SY; Han MW
    Cell Signal; 2018 Jul; 47():122-130. PubMed ID: 29653204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer.
    Kim SH; Kang BC; Seong D; Lee WH; An JH; Je HU; Cha HJ; Chang HW; Kim SY; Kim SW; Han MW
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients.
    de Jong MC; Ten Hoeve JJ; Grénman R; Wessels LF; Kerkhoven R; Te Riele H; van den Brekel MW; Verheij M; Begg AC
    Clin Cancer Res; 2015 Dec; 21(24):5630-8. PubMed ID: 26265694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periostin Plays a Key Role in Radioresistance of Head and Neck Cancer Cells
    Park JJ; Hah YS; Ryu S; Cheon SY; Cho HY; Kim JP; Won SJ; Lee JS; Hwa JS; Seo JH; Chang HW; Kim SY
    Anticancer Res; 2020 May; 40(5):2627-2635. PubMed ID: 32366407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
    Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
    Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.
    Yao YH; Cui Y; Qiu XN; Zhang LZ; Zhang W; Li H; Yu JM
    Chin J Cancer; 2016 Jun; 35():50. PubMed ID: 27266881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition.
    Yu X; Liu Y; Yin L; Peng Y; Peng Y; Gao Y; Yuan B; Zhu Q; Cao T; Xie B; Sun L; Chen Y; Gong Z; Qiu Y; Fan X; Li X
    Oncogene; 2019 Jan; 38(4):549-563. PubMed ID: 30158672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy-associated Furin Expression and Tumor Invasiveness in Recurrent Laryngeal Cancer.
    Lee M; Ryu CH; Chang HW; Kim GC; Kim SW; Kim SY
    Anticancer Res; 2016 Oct; 36(10):5117-5125. PubMed ID: 27798871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
    Kurth I; Hein L; Mäbert K; Peitzsch C; Koi L; Cojoc M; Kunz-Schughart L; Baumann M; Dubrovska A
    Oncotarget; 2015 Oct; 6(33):34494-509. PubMed ID: 26460734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of epithelial-mesenchymal transition by cetuximab via the EGFR-GEP100-Arf6-AMAP1 pathway in head and neck cancer.
    Matsumoto Y; Sakurai H; Kogashiwa Y; Kimura T; Matsumoto Y; Shionome T; Asano M; Saito K; Kohno N
    Head Neck; 2017 Mar; 39(3):476-485. PubMed ID: 27880014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiosensitivity and/or radioresistance of head and neck cancers: Biological angle].
    Guy JB; Rancoule C; Méry B; Espenel S; Wozny AS; Simonet S; Vallard A; Alphonse G; Ardail D; Rodriguez-Lafrasse C; Magné N
    Bull Cancer; 2016 Jan; 103(1):41-7. PubMed ID: 26702507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma.
    Hyakusoku H; Sano D; Takahashi H; Hatano T; Isono Y; Shimada S; Ito Y; Myers JN; Oridate N
    J Exp Clin Cancer Res; 2016 Jan; 35():6. PubMed ID: 26754630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Ku80 correlates with sensitivities to radiation in cancer cell lines of the head and neck.
    Chang HW; Kim SY; Yi SL; Son SH; Song DY; Moon SY; Kim JH; Choi EK; Ahn SD; Shin SS; Lee KK; Lee SW
    Oral Oncol; 2006 Nov; 42(10):979-86. PubMed ID: 16472552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterisation of acquired radioresistant breast cancer cell lines.
    Gray M; Turnbull AK; Ward C; Meehan J; Martínez-Pérez C; Bonello M; Pang LY; Langdon SP; Kunkler IH; Murray A; Argyle D
    Radiat Oncol; 2019 Apr; 14(1):64. PubMed ID: 30987655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of PI3K regulatory subunit p85 contributes to resistance against PI3K inhibitors in radioresistant head and neck cancer.
    Han MW; Ryu IS; Lee JC; Kim SH; Chang HW; Lee YS; Lee S; Kim SW; Kim SY
    Oral Oncol; 2018 Mar; 78():56-63. PubMed ID: 29496059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy.
    Lin TY; Chang JT; Wang HM; Chan SH; Chiu CC; Lin CY; Fan KH; Liao CT; Chen IH; Liu TZ; Li HF; Cheng AJ
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):246-56. PubMed ID: 20615631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cancer stem cell in radioresistant head and neck cancer.
    Park YM; Lee SY; Park SW; Kim SH
    Auris Nasus Larynx; 2016 Oct; 43(5):556-61. PubMed ID: 26860233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells.
    Lv XY; Wang J; Huang F; Wang P; Zhou JG; Wei B; Li SH
    Oncol Rep; 2018 Oct; 40(4):2408-2416. PubMed ID: 30066881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme.
    Day BW; Stringer BW; Al-Ejeh F; Ting MJ; Wilson J; Ensbey KS; Jamieson PR; Bruce ZC; Lim YC; Offenhäuser C; Charmsaz S; Cooper LT; Ellacott JK; Harding A; Leveque L; Inglis P; Allan S; Walker DG; Lackmann M; Osborne G; Khanna KK; Reynolds BA; Lickliter JD; Boyd AW
    Cancer Cell; 2013 Feb; 23(2):238-48. PubMed ID: 23410976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphA3 promotes malignant transformation of colorectal epithelial cells by upregulating oncogenic pathways.
    Li M; Yang C; Liu X; Yuan L; Zhang F; Wang M; Miao D; Gu X; Jiang S; Cui B; Tong J; Yu Z
    Cancer Lett; 2016 Dec; 383(2):195-203. PubMed ID: 27721017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.